This week 21st Century Television focuses on how Advanced Proteome has developed a patent-pending technology that combines multiple anti-cancer therapies in a single agent to directly target cancer tumors. Their technology is based on a proprietary protein modification platform which attaches entities to therapeutic proteins to enhance their properties and/or endow them with additional functions.
Advanced Proteome’s vision is to advance the field of protein-site targeting to deliver more effective and personalized cancer therapies faster, accelerate improvement in survival rates, while creating value for all of their stakeholders.
21st Century Television featuring Advanced Proteome will air on CNBC Thursday, November 7th at 11:30pm PST as pd. prog.
About 21st Century Television
21st Century Television is an award winning business and heath program that is independently produced by MMP (USA), Inc. The show provides its viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. With more than 5,000 companies participating on over 500 shows, 21st Century Television continues to be the premier and targeted outlet for the latest business and health stories. 21st Century Television airs on cable networks to over 100 million viewers.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21cbtv.com.
Distributed by 21st Century Television
Company Name:MMP (USA), Inc
Contact Person: Monique Healing
Email:moniqueh@mmpusa.com
Phone: 561-988-0609
Address:999 Yamato Road Suite 103
City: Boca Raton
State: Florida
Country: United States
Website: http://www.21cbtv.com/nov-13-clearance/21chtv2533-cnbc.pdf
0 comments:
Post a Comment